Search results for "Anticoagulation"

Results 1 - 10 of about 575 for "Anticoagulation".
Sort by: Relevance | Newest | Oldest

Switching to newer oral anticoagulant didn't benefit frail older patients with afib

A randomized trial that switched some frail atrial fibrillation patients from vitamin K antagonists (VKAs) to non-vitamin K oral anticoagulants found that such patients had more bleeding and no decrease in thromboembolic events compared to those who stayed on a VKA.
6 Sep 2023

FDA provides info on stimulant shortage

Also, a sterilizer for 3D-printed medical devices, a drug for postpartum depression, and an RSV vaccine for pregnant patients were approved, among other recent FDA actions.
30 Aug 2023

Chest physicians make 11 recommendations on antithrombotic therapy in COVID-19

The recommendations on prevention and management of arterial thrombosis and thromboembolism are not a major departure from prepandemic ones, according to an expert panel from the American College of Chest Physicians.
5 Jul 2023

Higher-dose prophylactic anticoagulation required to prevent thrombosis in hypoxemic COVID-19

Mortality and time to improvement didn't differ with twice the standard dose of heparin versus a standard or therapeutic dose, but there was a lower rate of new thromboembolic events with no increase in major bleeding, a French trial found.
29 Mar 2023

AHA issues scientific statement on managing atrial fibrillation during hospitalization

Acute manifestations of atrial fibrillation warrant clinical attention during hospitalization, at transitions of care, and over the long term, said the American Heart Association (AHA) statement, which reviewed triggers and treatments for the condition.
22 Mar 2023

Superior vena cava occlusion without malignancy

A patient with end-stage renal disease presented with one week of facial and left-arm edema.
15 Mar 2023

Aspirin noninferior to LMWH for prophylaxis after traumatic fractures, trial finds

All-cause mortality at 90 days was similar in hospitalized patients randomized to aspirin versus low-molecular-weight heparin (LMWH), and rates of deep venous thrombosis and pulmonary embolism were also low in both groups.
25 Jan 2023

DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis

A meta-analysis compared the direct oral anticoagulants (DOACs) apixaban, edoxaban, and rivaroxaban to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
4 Jan 2023

The year's top headlines

We collected the top five most read ACP Hospitalist articles of 2022 and identified some themes.
28 Dec 2022

AHA statement reviews efficacy, safety of CAM therapies in patients with heart failure

Potentially beneficial complementary and alternative medicine (CAM) therapies included omega-3 polyunsaturated fatty acids, coenzyme Q10, D-ribose, and L-carnitine, the American Heart Association (AHA) said.
14 Dec 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next